Prime Therapeutics: Blue Cross and Blue Shield of Alabama - Concerta (Methylphenidate ER)

Claims Processing Update for Blue Cross and Blue Shield of Alabama Covered Persons

Author: Angie Shirley/Friday, March 6, 2015/Categories: APCI Choice

Effective March 1, 2015, Covered Persons of Blue Cross and Blue Shield of Alabama will experience higher co-pay or coinsurance costs with prescription claims for generic Concerta (Methylphenidate ER). This medication will cause the Covered Person’s co-pay or coinsurance to be greater than normal because it is considered to be a branded product and will process at a brand rate.

Please see the attachment below for more information.

 

 

Comments are only visible to subscribers.